CLINICAL_TRIALS
trial_result
· 2020-06-04
Clinical Trial Update: A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age [Phase 2]
Summary
Phase 2 trial update for a multivalent pneumococcal conjugate vaccine in healthy adults 50-85; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pneumococcal Infections | Phase 2 | Status: COMPLETED | Results posted: 2020-06-04